[Questioning the efficiency of magnesium sulfate for the prevention of eclampsia in women with preeclampsia].
Berkane
N
N
Service de gynécologie obstétrique et médecine de la reproduction, hôpital Tenon, AP-HP, université Pierre-et-Marie-Curie, 4, rue de la Chine, 75020 Paris, France. nadia.berkane@tnn.aphp.fr
D002121:Calcium Channel Blockers / Q000009:adverse effects* / Q000627:therapeutic use*; D004461:Eclampsia / Q000517:prevention & control*; D005260:Female; D005333:Fetus / Q000187:drug effects; D006801:Humans; D008278:Magnesium Sulfate / Q000009:adverse effects* / Q000627:therapeutic use*; D011225:Pre-Eclampsia / Q000517:prevention & control; D011247:Pregnancy; D012307:Risk Factors; D016896:Treatment Outcome
D002121:Calcium Channel Blockers; D008278:Magnesium Sulfate